ALVO supply chain intelligence for Alvotech: verified suppliers, customers, debt relationships, acquisitions, and ownership data.
Data compiled by Redley Lamar · ChainSifter Intelligence
Alvotech (ALVO) is shown with relationship data already present in ChainSifter's database. Counts below come from stored supply-chain records and filing/source URLs where available; missing source URLs are not filled in or estimated.
| Ticker | Name | Confidence | Evidence |
|---|---|---|---|
| CONTRACT-MANUFACTURING-ORGANIZATIONS | CONTRACT-MANUFACTURING-ORGANIZATIONS | 90% | We partly rely on third-party manufacturers (contract manufacturing organizations, or “CMOs”) to manufacture and supply our product candidates for our preclinical and clinical studies |
| THIRD-PARTY-CONTRACTORS | THIRD-PARTY-CONTRACTORS | 80% | we rely on third parties to manufacture nonclinical and clinical supplies of our product candidates, to store critical components of our product candidates and perform various services related to the… |
| THIRD-PARTY-MANUFACTURING-VENDORS | THIRD-PARTY-MANUFACTURING-VENDORS | 80% | one or more of our third-party manufacturing vendors may be found on regulatory inspection by the FDA or other comparable foreign regulatory authorities to be noncompliant with cGMP regulations |
| KMDA | Kamada Ltd. | 72% | Reciprocal relationship from KMDA graph: Reciprocal relationship from ALVO graph: Reciprocal relationship from KMDA graph: Reciprocal relationship from ALVO graph: Reciprocal relationship from KMDA g… |
| LENZ | LENZ Therapeutics, Inc. | 72% | Reciprocal relationship from LENZ graph: Reciprocal relationship from ALVO graph: Reciprocal relationship from LENZ graph: Reciprocal relationship from ALVO graph: Reciprocal relationship from LENZ g… |
| TEVA | Teva Pharmaceutical Industries Limited | 72% | Reciprocal relationship from TEVA graph: nerics purchases, enabling each of them with significant bargaining power. Additionally, our customers may form commercial alliances which result in heightene… |
| TEVJF | Teva Pharmaceutical Industries Limited | 72% | Reciprocal relationship from TEVJF graph: Reciprocal relationship from ALVO graph: Reciprocal relationship from TEVJF graph: Reciprocal relationship from ALVO graph: Reciprocal relationship from TEVJ… |
| COLLABORATION-PARTNERS | COLLABORATION-PARTNERS | 70% | our collaboration partners and contract manufacturers are subject to significant regulation with respect to manufacturing our product candidates |
| CONTRACT-MANUFACTURING-PARTNERS | CONTRACT-MANUFACTURING-PARTNERS | 70% | Although we oversee our contract manufacturers, we cannot control the implementation of the manufacturing process by the contract manufacturing partners |
| THIRD-PARTY-VENDORS | THIRD-PARTY-VENDORS | 60% | we cannot be certain that identifying and establishing relationships for these services would not result in significant delay or increased cost in the development of our product candidates or manufac… |
| Ticker | Name | Confidence | Evidence |
|---|---|---|---|
| ABT | Abbott Laboratories | 72% | Reciprocal relationship from ABT graph: Reciprocal relationship from ALVO graph: ion, variation or revocation of an approval. As a result, our business, financial condition and results of operations … |
| ABT | Abbott Laboratories | 72% | ion, variation or revocation of an approval. As a result, our business, financial condition and results of operations may be materially harmed. Additionally, if supply from one approved manufacturer … |
| KMDA | Kamada Ltd. | 72% | Reciprocal relationship from KMDA graph: us with a prior notice of non-renewal of the agreement, prior any automatic renewal term. 52 Other Products In recent years, we sold small quantities of Human… |
| LENZ | LENZ Therapeutics, Inc. | 72% | Reciprocal relationship from LENZ graph: Item 1. Business Overview We are a commercial pharmaceutical company focused on the development and commercialization of innovative therapies to improve visio… |
| TEVA | Teva Pharmaceutical Industries Limited | 72% | Reciprocal relationship from TEVA graph: Reciprocal relationship from ALVO graph: Reciprocal relationship from TEVA graph: Reciprocal relationship from ALVO graph: Reciprocal relationship from TEVA g… |
| AMGN | Amgen Inc. | 62% | Reciprocal relationship from AMGN graph: Reciprocal relationship from ALVO graph: Reciprocal relationship from AMGN graph: Reciprocal relationship from ALVO graph: Reciprocal relationship from AMGN g… |
| COMPANY-OAKTREE-ACQUISITION-CORP | COMPANY-OAKTREE-ACQUISITION-CORP | 62% | or the year 27,919 ( 231,864 ) ( 551,731 ) Other comprehensive profit / (loss) Item that will be reclassified to profit or loss in subsequent periods: Exchange rate differences on translation of fore… |
| OAKTREE-ACQUISITION-CORP | OAKTREE-ACQUISITION-CORP | 62% | and cause misuse, disclosure, access, acquisition, loss, or damage to sensitive data, information systems, or other nosiness interruptions. We rely on third parties to operate critical business syste… |
| OAKTREE-ACQUISITION-HOLDINGS | OAKTREE-ACQUISITION-HOLDINGS | 62% | and cause misuse, disclosure, access, acquisition, loss, or damage to sensitive data, information systems, or other nosiness interruptions. We rely on third parties to operate critical business syste… |
| Instrument | Description | Confidence | Evidence |
|---|---|---|---|
| ALVO-DEBT | Debt stack $1.5B | 90% | Market cache reports total debt of $1.5B. |
| Holder | Name | Confidence | Evidence |
|---|---|---|---|
| ALVO-OWNER-VANGUARD-CAPITAL-MANAGEMENT-LLC | VANGUARD CAPITAL MANAGEMENT LLC | 95% | 13F/ownership overlay lists VANGUARD CAPITAL MANAGEMENT LLC; shares held 6,820,894; ownership 2.19%; value $23.7B; as of 2026-03-31. |
| ALVO-OWNER-BRACEBRIDGE-CAPITAL-LLC | Bracebridge Capital, LLC | 95% | 13F/ownership overlay lists Bracebridge Capital, LLC; shares held 2,705,304; value $9.3B; as of 2026-03-31. |
| ALVO-OWNER-VANGUARD-FIDUCIARY-TRUST-CO | VANGUARD FIDUCIARY TRUST CO | 95% | 13F/ownership overlay lists VANGUARD FIDUCIARY TRUST CO; shares held 974,228; value $3.4B; as of 2026-03-31. |
| ALVO-OWNER-MORGAN-STANLEY | MORGAN STANLEY | 95% | 13F/ownership overlay lists MORGAN STANLEY; shares held 673,572; value $3.6B; as of 2026-03-31. |
| ALVO-OWNER-PRICE-T-ROWE-ASSOCIATES-INC-MD | PRICE T ROWE ASSOCIATES INC /MD/ | 95% | 13F/ownership overlay lists PRICE T ROWE ASSOCIATES INC /MD/; shares held 1,397,107; value $4.8M; as of 2026-03-31. |
| ALVO-OWNER-LITTLEJOHN-CO-LLC | LITTLEJOHN & CO LLC | 95% | 13F/ownership overlay lists LITTLEJOHN & CO LLC; shares held 1,318,534; value $4.5B; as of 2026-03-31. |
| ALVO-OWNER-OAKTREE-CAPITAL-MANAGEMENT-LP | OAKTREE CAPITAL MANAGEMENT LP | 95% | 13F/ownership overlay lists OAKTREE CAPITAL MANAGEMENT LP; shares held 578,058; value $1.0B; as of 2026-03-31. |
| ALVO-OWNER-MILLENNIUM-MANAGEMENT-LLC | MILLENNIUM MANAGEMENT LLC | 95% | 13F/ownership overlay lists MILLENNIUM MANAGEMENT LLC; shares held 2,122,596; value $7.3B; as of 2026-03-31. |
| ALVO-OWNER-LEGAL-GENERAL-GROUP-PLC | Legal & General Group Plc | 95% | 13F/ownership overlay lists Legal & General Group Plc; shares held 504,460; value $1.7B; as of 2026-03-31. |
| ALVO-OWNER-BLACKROCK-INC | BlackRock, Inc. | 95% | 13F/ownership overlay lists BlackRock, Inc.; shares held 1,245,195; value $4.3B; as of 2026-03-31. |
| Ticker | Name | Chain Index | Hops | Relationship Types |
|---|---|---|---|---|
| GIKLY | Grifols, S.A. | 100.00 | 2 | |
| RDY | Dr. Reddy's Laboratories Limited | 100.00 | 2 | |
| TEVA | Teva Pharmaceutical Industries Limited | 100.00 | 1 | ['customer', 'supplier'] |
| GIFOF | Grifols, S.A. | 100.00 | 2 | |
| AMGN | Amgen Inc. | 100.00 | 1 | ['customer'] |
| ABT | Abbott Laboratories | 100.00 | 1 | ['customer'] |
| GRFS | Grifols, S.A. | 100.00 | 2 | |
| LENZ | LENZ Therapeutics, Inc. | 100.00 | 1 | ['customer', 'supplier'] |
| KMDA | Kamada Ltd. | 100.00 | 1 | ['customer', 'supplier'] |
| GRAL | GRAIL, Inc. | 50.00 | 2 | |
| CTMX | CytomX Therapeutics, Inc. | 50.00 | 2 | |
| GCTK | GlucoTrack, Inc. | 50.00 | 2 | |
| HAE | Haemonetics Corporation | 50.00 | 2 | |
| GILT | Gilat Satellite Networks Ltd. | 50.00 | 2 | |
| BIOA | BioAge Labs, Inc. | 50.00 | 2 | |
| AORT | Artivion, Inc. | 50.00 | 2 | |
| BBNX | Beta Bionics, Inc. | 50.00 | 2 | |
| CODX | Co-Diagnostics, Inc. | 50.00 | 2 | |
| CVRX | CVRx, Inc. | 50.00 | 2 | |
| BAX | Baxter International Inc. | 50.00 | 2 |